首页 | 本学科首页   官方微博 | 高级检索  
     

痰液脱落细胞中p16 基因和RASSF1A 基因甲基化与周边型非小细胞肺癌关系的研究
引用本文:孙楠 张林 刘永煜 郑世营 赵翔. 痰液脱落细胞中p16 基因和RASSF1A 基因甲基化与周边型非小细胞肺癌关系的研究[J]. 现代生物医学进展, 2012, 12(13): 2503-2510
作者姓名:孙楠 张林 刘永煜 郑世营 赵翔
作者单位:1. 中国医科大学附属第一医院胸外科 辽宁沈阳110001
2. 辽宁省肿瘤医院 辽宁沈阳110042
3. 苏州大学附属第一医院胸心外科 浙江苏州215006
基金项目:辽宁省自然科学基金项目(20102120)
摘    要:目的:探讨p16基因和RASSF1A基因甲基化与肺癌发生发展的关系和应用于诊断的意义。方法:采用甲基化特异性PCR(Methylation Specific PCR,MSP)检测120例周边型非小细胞肺癌患者癌组织、痰液脱落细胞和120例非肺癌人群的痰液脱落细胞中p16基因和RASSF1A基因甲基化,分析它们与临床特征的关系以及非肺癌人群与肿瘤患者之间的差异。结果:(1)120例周边型非小细胞肺癌组织中,p16基因甲基化率46.7%(56例),RASSF1A基因甲基化率53.3%(64例)。P16和RASSF1A基因甲基化与吸烟程度、肿瘤大小和临床分期正相关(P<0.05)。(2)肺癌痰液脱落细胞中有28例p16基因出现甲基化(23.3%),20例RASSF1A基因出现甲基化(16.7%),其中32例至少存在一个基因的甲基化(26.7%);66例重度吸烟者中只有4例痰液脱落细胞出现p16基因甲基化(6%),4例出现RASSF1A基因甲基化(6%);54例非重度吸烟正常人中仅有2例出现p16基因甲基化(3.7%),RASSF1A基因无甲基化。(3)液基痰细胞病理学检查与痰脱落细胞p16和RASSF1a基因甲基化检测结合起来可有效提高诊断的灵敏度(P<0.05)。结论:烟草可能具有潜在的诱导抑癌基因p16和RASSF1A发生甲基化的作用;p16和RASSF1A基因甲基化可能参与肺癌的生长过程。痰脱落细胞p16和RASSF1a基因甲基化检测结合液基痰细胞病理学诊断,可提高非小细胞肺癌诊断的灵敏度。

关 键 词:p16  RASSF1A  甲基化  非小细胞肺癌  MSP

Methylation of P16 and RASSF1A Genes in Sputum Samples Associatedwith Peripheral Non-Small Cell Lung Cancer
SUN Nan,ZHANG Lin,LIU Yong-yu,ZHENG Shi-ying,ZHAO Xiang. Methylation of P16 and RASSF1A Genes in Sputum Samples Associatedwith Peripheral Non-Small Cell Lung Cancer[J]. Progress in Modern Biomedicine, 2012, 12(13): 2503-2510
Authors:SUN Nan  ZHANG Lin  LIU Yong-yu  ZHENG Shi-ying  ZHAO Xiang
Affiliation:1 Department of Thoracic Surgery,China Medical University First Hospital,110001,Shenyang,China;2 Department of Thoracic Surgery,Liaoning Tumor Hospital,110042,Shenyang,China;3 Department of Thoracocardiac Surgery,The First Affiliated Hospital of Suzhou University,215006,Suzhou,China)
Abstract:Objective: To investigate the relativity between p16 and RASSF1A gene methylation and development of peripheral non-small cell lung cancer,and investigate the value of detection of p16 and RASSF1A gene methylation in sputum cells as diagnosis method of non-small cell lung cancer.Methods: Methylation-specific PCR(MSP) was performed to detect the methylation status of p16 and RASSF1A genes in tissue and sputum cells of 120 cases of peripheral non-small cell lung cancer,and in sputum cells of 120 cases of cancer-free.The relationship between the methylation status and the clinic factors was analyzed.Results:(1) The frequencies of methyla-tion of the p16 and RASSF1a genes in tissue of peripheral non-small cell lung cancer were: 46.7%(56 of 120) and 53.3%(64 of 120).There was a significant higher ratio of p16 and RASSF1A gene methylation in the degree of smoking,size of tumor and advanced clinical stage(P<0.05).(2) The frequencies of methylation of the genes in sputum of non-small cell lung cancer,heavy-smoking and normal samples were: 23.3%(28 of 120),6%(4 of 66) and 3.7%(2 of 54) for p16,and 16.7%(20 of 120),6%(4 of 66) and 0(0 of 54) for RASSF1A,respectively.(3) Combination of Liquid-based cytological analysis and detection of p16 and RASSF1a genes methylation in sputum could increase the sensitivity of diagnostic approach for non-small cell lung cancer(P<0.05).Conclusion: These results indicate that the tobacco may have the potential capability to induce methylation of p16 and RASSF1A genes.In addition,the Methylation of p16 and RASSF1A maybe play important roles in growth process of non-small cell lung cancer.Combination of Liquid-based cytological analysis and detection of p16 and RASSF1a genes methylation in sputum could be a more sensitive method for the diagnosis of this ma-lignancy.
Keywords:p16  RASSF1A  Methylation  Non——small cell lung cancer  MSP
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号